Woman Claims Enbrel Maker Allegedly Failed to Warn of Drug's Ability to Cause MS



DOCUMENTS
  • Complaint
  • Notice of Removal



FORT WORTH, Texas - A woman who allegedly developed multiple sclerosis as a result of using the rheumatoid arthritis drug Enbrel claims the manufacturer of the drug failed to adequately warn consumers of its ability to cause the central nervous system disorder. Randa Hahn v. Amgen, Inc., et al., No. 017-199258-03 (Texas Dist. Ct., Tarrant Cty.).

The suit, filed in the District Court of Tarrant County, Texas, stated that although post-marketing reports involving patients who developed infections and central nervous system disorders started first appearing five months after Enbrel was approved by the FDA in 1998, Amgen, the drug's …






UPCOMING CONFERENCES




HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

April 08, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS



HarrisMartin's Webinar Series: Water Contamination Litigation Presented by EisnerAmper

May 06, 2025

MORE DETAILS